FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079759594> ?p ?o ?g. }

• W2079759594 endingPage "845" @default.
• W2079759594 startingPage "835" @default.
• W2079759594 abstract "Objective. To compare the clinical efficacy of certolizumab pegol (CZP) with that of other anticytokine agents indicated for the treatment of rheumatoid arthritis (RA) with identical therapeutic indication (anti-tumor necrosis factor-α, anti-interleukin 1 or 6), with the objective of determining the noninferiority of CZP. Methods. A systematic review was performed to identify randomized controlled trials that assessed the efficacy of anticytokine agents in combination with conventional disease-modifying antirheumatic drugs (DMARD) after 6 months of treatment, using the American College of Rheumatology (ACR) response criteria, in patients with RA who have shown inadequate response to DMARD including methotrexate. Indirect treatment comparisons were carried out by a multiple-treatment Bayesian random-effects metaanalysis. Data were analyzed using the Markov chain Monte Carlo simulation. Noninferiority of CZP was assessed in comparison with a predefined equivalence margin of 5%. Results. Nineteen placebo-controlled studies were identified: 14 evaluated the efficacy of 5 anti-TNF-α agents (infliximab, etanercept, adalimumab, golimumab, CZP) and 5 evaluated efficacy of 2 anti-interleukin agents (anakinra, tocilizumab). Every treatment showed significant efficacy versus placebo in individual studies. The multiple-treatment metaanalysis showed a highest OR for CZP on ACR20 response. Metaanalysis indicates that the efficacy of CZP according to ACR20 response is superior to that of infliximab, adalimumab, and anakinra, and equivalent or superior to that of etanercept, golimumab, and tocilizumab. According to ACR50 response, the efficacy of CZP is equivalent or superior to that of all other anticytokines. Conclusion. Results of this original multiple-treatment Bayesian metaanalysis indicate that certolizumab pegol is at least as efficacious as the preexisting antirheumatic anticytokine biotherapies." @default.
• W2079759594 created "2016-06-24" @default.
• W2079759594 creator A5002312620 @default.
• W2079759594 creator A5005382548 @default.
• W2079759594 creator A5008811878 @default.
• W2079759594 creator A5015032522 @default.
• W2079759594 creator A5053424083 @default.
• W2079759594 creator A5080881858 @default.
• W2079759594 creator A5085771274 @default.
• W2079759594 creator A5086914602 @default.
• W2079759594 creator A5091166604 @default.
• W2079759594 date "2011-01-15" @default.
• W2079759594 modified "2023-10-17" @default.
• W2079759594 title "Comparison of Certolizumab Pegol with Other Anticytokine Agents for Treatment of Rheumatoid Arthritis: A Multiple-treatment Bayesian Metaanalysis" @default.
• W2079759594 cites W1979364075 @default.
• W2079759594 cites W1982319419 @default.
• W2079759594 cites W1985763670 @default.
• W2079759594 cites W1986215651 @default.
• W2079759594 cites W1994065448 @default.
• W2079759594 cites W2000962647 @default.
• W2079759594 cites W2006566716 @default.
• W2079759594 cites W2010984604 @default.
• W2079759594 cites W2015215846 @default.
• W2079759594 cites W2020999234 @default.
• W2079759594 cites W2046628605 @default.
• W2079759594 cites W2056271161 @default.
• W2079759594 cites W2063485775 @default.
• W2079759594 cites W2097341637 @default.
• W2079759594 cites W2097997129 @default.
• W2079759594 cites W2107328434 @default.
• W2079759594 cites W2108650270 @default.
• W2079759594 cites W2113144077 @default.
• W2079759594 cites W2119772850 @default.
• W2079759594 cites W2125212735 @default.
• W2079759594 cites W2134143967 @default.
• W2079759594 cites W2141036320 @default.
• W2079759594 cites W2145249112 @default.
• W2079759594 cites W2150952126 @default.
• W2079759594 cites W2154515402 @default.
• W2079759594 cites W2158058290 @default.
• W2079759594 cites W2159106700 @default.
• W2079759594 cites W2162254515 @default.
• W2079759594 cites W2163817180 @default.
• W2079759594 cites W2169853546 @default.
• W2079759594 cites W2170415825 @default.
• W2079759594 cites W2314052274 @default.
• W2079759594 cites W27765219 @default.
• W2079759594 cites W3022903699 @default.
• W2079759594 cites W334564628 @default.
• W2079759594 cites W4211239818 @default.
• W2079759594 cites W4361867558 @default.
• W2079759594 doi "https://doi.org/10.3899/jrheum.100665" @default.
• W2079759594 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21239748" @default.
• W2079759594 hasPublicationYear "2011" @default.
• W2079759594 type Work @default.
• W2079759594 sameAs 2079759594 @default.
• W2079759594 citedByCount "46" @default.
• W2079759594 countsByYear W20797595942012 @default.
• W2079759594 countsByYear W20797595942013 @default.
• W2079759594 countsByYear W20797595942014 @default.
• W2079759594 countsByYear W20797595942015 @default.
• W2079759594 countsByYear W20797595942016 @default.
• W2079759594 countsByYear W20797595942017 @default.
• W2079759594 countsByYear W20797595942018 @default.
• W2079759594 countsByYear W20797595942019 @default.
• W2079759594 countsByYear W20797595942020 @default.
• W2079759594 crossrefType "journal-article" @default.
• W2079759594 hasAuthorship W2079759594A5002312620 @default.
• W2079759594 hasAuthorship W2079759594A5005382548 @default.
• W2079759594 hasAuthorship W2079759594A5008811878 @default.
• W2079759594 hasAuthorship W2079759594A5015032522 @default.
• W2079759594 hasAuthorship W2079759594A5053424083 @default.
• W2079759594 hasAuthorship W2079759594A5080881858 @default.
• W2079759594 hasAuthorship W2079759594A5085771274 @default.
• W2079759594 hasAuthorship W2079759594A5086914602 @default.
• W2079759594 hasAuthorship W2079759594A5091166604 @default.
• W2079759594 hasBestOaLocation W20797595941 @default.
• W2079759594 hasConcept C112705442 @default.
• W2079759594 hasConcept C126322002 @default.
• W2079759594 hasConcept C142724271 @default.
• W2079759594 hasConcept C17991360 @default.
• W2079759594 hasConcept C204787440 @default.
• W2079759594 hasConcept C27081682 @default.
• W2079759594 hasConcept C2776215756 @default.
• W2079759594 hasConcept C2777138892 @default.
• W2079759594 hasConcept C2777178219 @default.
• W2079759594 hasConcept C2777226972 @default.
• W2079759594 hasConcept C2777575956 @default.
• W2079759594 hasConcept C2779134260 @default.
• W2079759594 hasConcept C2780132546 @default.
• W2079759594 hasConcept C2781228260 @default.
• W2079759594 hasConcept C2781290027 @default.
• W2079759594 hasConcept C42404028 @default.
• W2079759594 hasConcept C71924100 @default.
• W2079759594 hasConcept C98274493 @default.
• W2079759594 hasConceptScore W2079759594C112705442 @default.
• W2079759594 hasConceptScore W2079759594C126322002 @default.
• W2079759594 hasConceptScore W2079759594C142724271 @default.

• next